Is LEVALBUTEROL 0,63 mg/3 ml CIPLA registered in South Africa?

LEVALBUTEROL 0,63 mg/3 ml CIPLA is recorded with registration status “Registered” in South Africa, registration number 54/10.2.1/0628, based on SAHPRA data.

What is the active ingredient in LEVALBUTEROL 0,63 mg/3 ml CIPLA?

LEVALBUTEROL 0,63 mg/3 ml CIPLA contains None.

Registered South Africa · SAHPRA

LEVALBUTEROL 0,63 mg/3 ml CIPLA

None

54/10.2.1/0628

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.

54/10.2.1/0628

Registration date

2023/04/04

Expiry date

Status

Registered

Active ingredient

None

Dosage form

Strength

Pack size

Therapeutic class

Manufacturer / MAH

Applicant / LTR

Cipla Medpro (Pty) Ltd

Country of origin

Source: South African Health Products Regulatory Authority · fetched 2026-04-15 21:28:01 · updated 2026-09-20 04:02:02

Disclaimer: This information is sourced from South African Health Products Regulatory Authority (South Africa). Always consult a qualified healthcare professional before using any medication.